Crédit Industriel et Commercial’s AstraZeneca AZN Stock Holding History

Crédit Industriel et Commercial’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Sell	1,407 -72	-5%	-$13.5K	0.02%	263
2026 Q1	$288K	Buy	+1,479	New	+$285K	0.02%	276

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Crédit Industriel et Commercial's AZN Position: Q2 2026 in Review

Crédit Industriel et Commercial reduced its AstraZeneca (AZN) stake by 4.9% in Q2 2026, selling an estimated $13.5K and leaving 1,407 shares worth $262K. The position accounts for 0.02% of the portfolio, ranked #263.

Crédit Industriel et Commercial first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $288K in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Crédit Industriel et Commercial held 1,407 shares of AstraZeneca worth $262K as of Q2 2026.
Crédit Industriel et Commercial sold 72 AstraZeneca shares in Q2 2026, an estimated $13.5K.
AstraZeneca made up 0.02% of Crédit Industriel et Commercial's portfolio in Q2 2026, its #263 holding.
Crédit Industriel et Commercial first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
Crédit Industriel et Commercial's AstraZeneca position peaked at $288K in Q1 2026.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.